AGEN

AGEN

USD

Agenus Inc. Common Stock

$3.980+0.140 (3.646%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$3.840

最高价

$3.980

最低价

$3.700

成交量

0.33M

公司基本面

市值

126.8M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.46M

交易所

NCM

货币

USD

52周价格范围

最低价 $1.38当前价 $3.980最高价 $7.34

相关新闻

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

查看更多
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
BusinessWire

France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable

查看更多
France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Earnings Call Transcripts

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

查看更多
Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)
PR Newswire

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with...

查看更多
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

查看更多
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
BusinessWire

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Webcast details updated from the August 11th release Webcast on Wednesday, August 27, 2025 at 4:00 p.m. EST Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its